SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001140361-23-020595
Filing Date
2023-04-26
Accepted
2023-04-26 16:31:07
Documents
4
Period of Report
2023-06-07

Document Format Files

Seq Description Document Type Size
1 DEF 14A ny20007692x1_def14a.htm DEF 14A 543147
2 logo_moonlake.jpg GRAPHIC 30176
3 ny20007692x1_pc01.jpg GRAPHIC 562747
4 ny20007692x1_pc02.jpg GRAPHIC 625685
  Complete submission text file 0001140361-23-020595.txt   2221808
Mailing Address DORFSTRASSE 29 ZUG V8 6300
Business Address DORFSTRASSE 29 ZUG V8 6300 41 41 510 8022
MoonLake Immunotherapeutics (Filer) CIK: 0001821586 (see all company filings)

IRS No.: 000000000 | State of Incorp.: E9 | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-39630 | Film No.: 23850228
SIC: 2834 Pharmaceutical Preparations